Investing Profile

Cory Freedland

InvestorVC
Principal at Samsara BioCapital
samsaracap.com/cory-freedland...San Francisco Bay Area
Photo of Cory Freedland, Principal at Samsara BioCapital
cb
$1M - $100.0M
$25.0M
4
$310.1M
CompanyStageDateRound SizeTotal Raised
Alpha9 Theranostics
Series COct 2024$180M
Series BDec 2022$75M
$250M
Co-investors: Patrick Heron (Frazier Healthcare Partners), Melissa McCracken (Nextech Invest)
Palvella Therapeutics
Series CMay 2020$45M
$45M
Velicept Therapeutics
Series BOct 2018$15M
$15M